Distal esophageal resection and jejunum interposition for early Barrett carcinoma
Summary
Limited resection with regional lymphadenectomy and jejunal interposition is safe,
prevents gastroesophageal reflux and is associated with good quality of life. The
procedure represents an oncologically adequate and thus attractive limited surgical
alternative to radical esophagectomy or endoscopic resection and ablation techniques
in patients with high grade dysplasia or T1 adenocarcinoma in Barrett's esophagus.
Zusammenfassung
Eine limitierte Resektion des distalen Ösophagus und ösophagogastralen Übergangs mit
regionaler Lymphadenektomie stellt eine onkologisch adäquate chirurgische Alternative
zur radikalen Ösophagektomie oder endoskopischen Mukosaresektion bei Patienten mit
hochgradiger Dysplasie oder T1-Karzinom im Barrett-Ösophagus dar. Rekonstruktion mittels
Interposition eines gestielten isoperistaltischen Jejunumsegments ist sicher, verhindert
gastro-ösophagealen Reflux und resultiert in einer guten Lebensqualität.
Key words
Barrett's esophagus - high grad dysplasia - early cancer - limited resection - esophagectomy
- endoscopic mucosa resection
Schlüsselwörter
Barrett-Ösophagus - hochgradige Dysplasie - Frühkarzinom - limitierte Resektion -
Ösophagektomie - endoskopische Mukosaresektion
Literatur
- 1
Ell C, May A, Gossner L, Pech O, Günter E, Mayer G, Henrich R, Vieth M, Müller H,
Seitz G, Stolte M.
Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's
esophagus.
Gastroenterology.
2000;
118
670-677
- 2
Eypasch E P, Williams J I, Wood-Dauphinee S, Ure B M, Schmülling C, Neugebauer E,
Troidl H.
Gastrointestinal Quality of Life Index: development, validation and application of
a new instrument.
Br J Surg.
1995;
82
216-222
- 3
Gossner L, May A, Stolte M, Seitz G, Hahn E G, Ell C.
KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.
Gastrointest Endosc.
1999;
49
8-12
- 4
Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn E G, Ell C.
Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus
by means of 5-aminolevulinic acid.
Gastroenterology.
1998;
114
448-455
- 5
Hagen J A, Peters J H, DeMeester T R.
Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus
and cardia.
J Thorac Cardiovasc Surg.
1993;
106
850-859
- 6
Hölscher A H, Bollschweiler E, Schneider P M, Siewert J R.
Early adenocarcinoma in Barrett's oesophagus.
Br J Surg.
1997;
84
1470-1473
- 7
Kirby J D.
Quality of life after oesophagectomy: the patients' perspective.
Dis Esophagus.
1999;
12
168-171
- 8
Merendino K A, Dillard D H.
The concept of sphincter substitution by an interposed jejunal segment for anatomic
and physiological abnormalities at the esophagogastric junction.
Ann Surg.
1955;
142
486-506
- 9
Nigro J J, Hagen J A, DeMeester T R, DeMeester S R, Peters J H, Oberg S, Theisen J,
Kiyabu M, Crookes P F, Bremner C.
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined
to the wall: implications for therapy.
J Thorac Cardiovasc Surg.
1999;
117
16-23
- 10
Nigro J J, Hagen J A, DeMeester T R, DeMeester S R, Theisen J, Peters J H, Kiyabu M.
Occult esophageal adenocarcinoma: extent of disease and implications for effective
therapy.
Ann Surg.
1999;
230
433-438
- 11
Riben M, Ilves R, McKenna B J.
Second primary Barrett's adenocarcinoma after 19 years.
Ann Thorac Surg.
1999;
67
1796-1798
- 12
Rusch V W, Levine D S, Haggitt R, Reid B J.
The management of high grade dysplasia and early cancer in Barrett's esophagus. A
multidisciplinary problem.
Cancer.
1994;
74
1225-1229
- 13
Sharma P, Jaffe P E, Bhattacharyya A, Sampliner R E.
Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma:
long-term follow-up.
Gastrointest Endosc.
1999;
49
442-446
- 14
Siewert J R, Stein H J.
Barrett's cancer: Indications, extent and results of surgical resection.
Sem Surg Oncol.
1997;
13
245-252
- 15
Siewert J R, Stein H J.
Lymphadenectomy for esophageal cancer.
Langenbecks Arch Surg.
1999;
384
141-148
- 16 Sobin L H, Wittekind C. International Union Against Cancer (UICC) (eds) .TNM classification
of malignant tumors. 5th edn. Wiley & Sons 1997
- 17
Stein H J, Feith M, Feussner H.
The relationship between gastroesophageal reflux, development of Barrett's epithelium
and cancer of the esophagus.
Langenbecks Arch Surg.
2000;
385
309-316
- 18
Stein H J, Feith M, Siewert J R.
Malignant degeneration of Barrett's esophagus. Clinical point of view.
Rec Res Canc Res.
2000;
155
119-122
- 19
Stein H J, Feith M, Müller J, Werner M, Siewert J R.
Limited resection for early Barrett's cancer.
Ann Surg.
2000;
232
733-742
- 20
van Sandick J W, van Lanschot J J, Kuiken B W, Tytgat G N, Offerhaus G J, Obertop H.
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage
and clinical outcome of Barrett's carcinoma.
Gut.
1998;
43
216-222
- 21
Wright C, Cuschieri A.
Jejunal interposition for benign esophageal disease. Technical considerations and
long-term results.
Ann Surg.
1987;
205
54-60
Priv.-Doz. Dr. Hubert J. Stein
Chirurgische Klinik und Poliklinik
Klinikum rechts der Isar der TU München
Ismaningerstraße 22
D-81675 München
Phone: 0 89/41 40 47 45
Fax: 0 89/41 40 49 40
Email: stein@nt1.chir.med.tu-muenchen.de
